VIATRIS INC. (VTRS) ROE
- 2020-12-31: ROE -2.92%.
- 2020-09-27: ROE 84.53%.
- 2020-06-28: ROE 90.00%.
Complete source-backed roe history.
- Available history
- 2018-12-31 to 2025-12-31
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2020-12-31 | -2.92% |
| 2020-09-27 | 84.53% |
| 2020-06-28 | 90.00% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -23.89% |
| 2024-12-31 | -3.40% |
| 2023-12-31 | 0.27% |
| 2022-12-31 | 9.86% |
| 2021-12-31 | -6.19% |
| 2020-12-31 | -2.92% |
| 2018-12-31 | 2.90% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |